Publications by authors named "D Vassiliadi"

Cortisol is released upon activation of the hypothalamic-pituitary-adrenal axis, varies across the day, possesses an underlying diurnal rhythm and is responsive to stressors. The endogenous circadian peak of cortisol occurs in the morning, and increases in cortisol observed post-awakening have been named the cortisol awakening response (CAR) based on the belief that the act of waking up stimulates cortisol secretion. However, objective evidence that awakening induces cortisol secretion is limited.

View Article and Find Full Text PDF
Article Synopsis
  • Atypical teratoid/rhabdoid tumor (AT/RT) is a rare brain cancer mainly found in children, but can appear in adults, especially in the sellar region of middle-aged women.
  • A case study is presented of a 51-year-old woman with AT/RT who had headaches and left ptosis, leading to a diagnosis and treatment that included surgery, radiation, and chemotherapy.
  • Despite treatment, the patient developed lung metastases and passed away seven months post-diagnosis, highlighting the need for further awareness of AT/RT in adults, particularly when considering sellar masses.
View Article and Find Full Text PDF

Objective: Critically ill patients, including those with brain injuries (BI), are frequently hospitalized in an intensive care unit (ICU). As with other critical states, an adequate stress response is essential for survival. Research on the hypothalamic-pituitary-adrenal gland (HPA) axis function in BI has primarily focused on assessing ACTH and cortisol levels.

View Article and Find Full Text PDF

Background: Diabetes mellitus (DM) is tightly associated with the increased prevalence of diabetic kidney disease (DKD). Nonetheless, severe renal function impairment and/or nephrotic range-proteinuria could also result from non-diabetic renal disease (non-DRD) among patients with DM. The 'Gold standard' for the differential diagnosis between DKD and non-DRD is kidney biopsy, although no real consensus exists.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined serum levels of GFAP, s100b, and total Tau in long-COVID patients to investigate links to symptoms, cognitive decline, mental health issues, and quality of life.
  • - It included 65 long-COVID patients and 20 controls, finding that GFAP levels were higher in patients but didn’t correlate with long-COVID symptoms; other biomarkers like s100b and total Tau showed no significant difference.
  • - The research highlighted high rates of cognitive decline (65.9%), depression (32.2%), anxiety (47.5%), and PTSD (44.1%) among long-COVID patients, with most participants scoring below normal on quality of life assessments.
View Article and Find Full Text PDF